Cambridge, United Kingdom · Founded 2020 · Privately Held (backing)
Developer of a biotechnology platform designed to develop tools for large-scale analysis of genetic variations and gene function. Enhanced Genomics is based in Cambridge, United Kingdom and was founded in 2020. Its last reported valuation was $28.1 million in Sep 2025. It has raised $21.8 million.
Last reported valuation
$28.1M
Oct 2026
Priced at
—
Total raised
$21.8M
Last round
—
Team — not yet on record
No current team members for Enhanced Genomics are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Enhanced Genomics with a free account
·Watch Enhanced Genomics: the Monday email on marks, rounds and moves
